Skip to content

Clinical trials

Phase 3 Endocrine System Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Phase: Phase 3 Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20051
20071
20081
20092
20103
20123
20132
20143
20162
20172
20181
20191
20203
20214
20222
20232
20243
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated5
Active, not recruiting4
Recruiting4
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
AstraZeneca6
Pfizer5
Ascendis Pharma Endocrinology Division A/S4
Ascendis Pharma A/S2
Ascendis Pharma Bone Diseases A/S2
Merck Sharp & Dohme LLC2
University of Nottingham2
Visen Pharmaceuticals (Shanghai) Co., Ltd.2
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases45
Metabolic Diseases23
Diabetes Mellitus, Type 222
Glucose Metabolism Disorders22
Diabetes Mellitus18
Dwarfism, Pituitary6
Failure to Thrive5
Hypoparathyroidism4
Parathyroid Diseases4
Pituitary Diseases4

Trials

Showing 26 to 45 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.